Evidence map›Paper›PMID 39505929›Full record

ArticleScientific reports2024

Microbial education plays a crucial role in harnessing the beneficial properties of microbiota for infectious disease protection in Crassostrea gigas.

Luc Dantan, Prunelle Carcassonne, Lionel Degrémont, Benjamin Morga, Marie-Agnès Travers, Bruno Petton, Mickael Mege, Elise Maurouard, Jean-François Allienne, Gaëlle Courtay and 8 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Luc DantanIHPE, Univ Perpignan Via Domitia, CNRS, IFREMER, Univ Montpellier, Perpignan, France. luc.dantan@gmail.com.
Prunelle CarcassonneIHPE, Univ Perpignan Via Domitia, CNRS, IFREMER, Univ Montpellier, Perpignan, France.
Lionel DegrémontIfremer, ASIM, La Tremblade, F- 17390, France.
Benjamin MorgaIfremer, ASIM, La Tremblade, F- 17390, France.
Marie-Agnès TraversIHPE, Univ Montpellier, CNRS, IFREMER, Univ Perpignan Via Domitia, Montpellier, France.
Bruno PettonUniv Brest, CNRS, IRD, LEMAR, Ifremer, Plouzané, F-29280, France.
Mickael MegeIfremer, ASIM, La Tremblade, F- 17390, France.
Elise MaurouardIfremer, ASIM, La Tremblade, F- 17390, France.
Jean-François AllienneIHPE, Univ Perpignan Via Domitia, CNRS, IFREMER, Univ Montpellier, Perpignan, France.
Gaëlle CourtayIHPE, Univ Montpellier, CNRS, IFREMER, Univ Perpignan Via Domitia, Montpellier, France.
Océane RomatifIHPE, Univ Montpellier, CNRS, IFREMER, Univ Perpignan Via Domitia, Montpellier, France.
Juliette PouzadouxIHPE, Univ Montpellier, CNRS, IFREMER, Univ Perpignan Via Domitia, Montpellier, France.
Raphaël LamiLaboratoire de Biodiversité et Biotechnologies Microbiennes, Sorbonne Université, CNRS, Observatoire Océanologique de Banyuls-sur-Mer, Avenue Pierre Fabre, Banyuls-sur- Mer, 66650, France.
Laurent IntertagliaSorbonne Université, CNRS, Fédération de Recherche, Observatoire Océanologique de Banyuls-sur-Mer, Banyuls-sur-Mer, 66650, France.
Yannick GueguenMARBEC, Univ Montpellier, CNRS, Ifremer, IRD, Sète, France.
Jeremie Vidal-DupiolIHPE, Univ Montpellier, CNRS, IFREMER, Univ Perpignan Via Domitia, Montpellier, France.
Eve ToulzaIHPE, Univ Perpignan Via Domitia, CNRS, IFREMER, Univ Montpellier, Perpignan, France.
Céline CosseauIHPE, Univ Perpignan Via Domitia, CNRS, IFREMER, Univ Montpellier, Perpignan, France. celine.cosseau@univ-perp.fr.

Funding

ANR DECICOMP ANR-19-CE20-0004Fond Européen pour les Affaires Maritimes et la Pêche (FEAMP, GESTINNOV ) n°PFEA470020FA1000007Laboratoires d'Excellences (LABEX): CEMEB ANR-10-LABX-04-01Laboratoires d'Excellences (LABEX): TULIP ANR-10-LABX-41
6 · The paper itself

Abstract

The increase in marine diseases, particularly in economically important mollusks, is a growing concern. Among them, the Pacific oyster (Crassostrea gigas) production faces challenges from several diseases, such as the Pacific Oyster Mortality Syndrome (POMS) or vibriosis. The microbial education, which consists of exposing the host immune system to beneficial microorganisms during early life stages is a promising approach against diseases. This study explores the concept of microbial education using controlled and pathogen-free bacterial communities and assesses its protective effects against POMS and Vibrio aestuarianus infections, highlighting potential applications in oyster production. We demonstrate that it is possible to educate the oyster immune system by adding microorganisms during the larval stage. Adding culture based bacterial mixes to larvae protects only against the POMS disease while adding whole microbial communities from oyster donors protects against both POMS and vibriosis. The efficiency of immune protection depends both on oyster origin and on the composition of the bacterial mixes used for exposure. No preferential protection was observed when the oysters were stimulated with their sympatric strains. Furthermore, the added bacteria were not maintained into the oyster microbiota, but this bacterial addition induced long term changes in the microbiota composition and oyster immune gene expression. Our study reveals successful immune system education of oysters by introducing beneficial microorganisms during the larval stage. We improved the long-term resistance of oysters against critical diseases (POMS disease and Vibrio aestuarianus infections) highlighting the potential of microbial education in aquaculture.

Indexed as

CrassostreaMicrobiotaVibrioAnimalsAquacultureLarvaVibrio InfectionsCrassostrea gigasMicrobial educationOsHV-1 µVarOyster holobiontVibrio aestuarianus

Identifiers

PMID39505929
PMCPMC11541537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.